Home›Search›Frontiers in Clinical Drug Research - HIV
Frontiers in Clinical Drug Research - HIV
Bentham Science Publishers · United Arab Emirates · Est. 2019
ISSN2352-5916
SJR Q4✓ Scopus / SJR
5
/ 100
High Risk
Score Breakdown
✓ Scopus Q4+5
Total5
Journal Impact Factor
Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.
SJR Score
0.114
H-Index
1
Total Works
18
Total Citations
4
2yr Mean Citedness
0.00
Free JIF alternative
Aims & Scope✦ Inferred from recent articles
This journal focuses on the development, mechanisms, and challenges of drugs and therapies for human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS). It covers antiretroviral therapy (ART), including drug combinations, resistance, and novel treatment strategies like "shock and kill" and gene editing. The scope also extends to drug delivery systems, such as nanotechnology and nanovehicles for brain targeting, and the synthesis of cost-effective drugs. Additionally, it addresses co-infections associated with HIV and the role of specific drug classes like protease inhibitors and integrase strand transfer inhibitors.
AI-summarised from recent articles · verify on the publisher page
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
HIV/AIDS drug development and treatmentHIV Research and TreatmentHIV/AIDS Research and InterventionsHIV-related health complications and treatmentsLegal Cases and CommentaryPneumocystis jirovecii pneumonia detection and treatmentDiverse Scientific and Economic StudiesHuman auditory perception and evaluationNanoparticle-Based Drug DeliveryReproductive tract infections research